A preliminary study on the radiation-resistance mechanism in ovarian cancer

Qi Liao1, Hong-mei Zhang, Hai-hua Li

  • 1Department of Radiotherapy, Second Teaching Hospital of Jilin University, Changchun, China.

Abstract

Insights

Checkpoint kinase 1 (CHK1) and DNA-activated protein kinase (DNA-PK) gene interference using shRNA enhanced radiation-induced apoptosis in ovarian cancer cells, suggesting their role in radiation resistance.

Area of Science:

  • Oncology
  • Molecular Biology
  • Genetics

Background:

  • Ovarian and cervical cancers exhibit varying responses to radiation therapy.
  • Understanding the molecular mechanisms of radiation resistance is crucial for improving treatment efficacy.

Purpose of the Study:

  • To investigate the role of Checkpoint Kinase 1 (CHK1) and DNA-Activated Protein Kinase (DNA-PK) in radiation resistance.
  • To explore the effects of short hairpin RNA (shRNA) targeting CHK1 and DNA-PK on cancer cell apoptosis following radiation exposure.

Main Methods:

  • Skov3 (ovarian) and HeLa (cervical) cancer cells were transfected with CHK1 and DNA-PK shRNA using Lipofectamine™ 2000.
  • Cells were exposed to 2 Gy X-radiation and apoptosis was analyzed at 4 and 28 hours post-irradiation using Annexin V/PI staining and flow cytometry.

Main Results:

  • Skov3 cells exhibited significantly lower apoptotic response to X-radiation compared to HeLa cells at both 4 and 28 hours post-irradiation.
  • While shRNA alone did not significantly affect apoptosis, shRNA-transfection enhanced the radiation-induced apoptotic response in Skov3 cells relative to HeLa cells.

Conclusions:

  • CHK1 and DNA-PK genes are implicated in the development of radiation resistance in ovarian cancer.
  • Targeting CHK1 and DNA-PK may represent a potential strategy to overcome radiation resistance in ovarian cancer.